Select Page

Heritage, Apotex plan to pay $49.1 million to settle drug pricing scheme allegations

Heritage, Apotex plan to pay $49.1 million to settle drug pricing scheme allegations

Two pharmaceutical companies will pay $49.1 million to resolve allegations that they inflated prices, reduced competition and restricted access to generic drugs, Attorney General Josh Kaul said Thursday. 

To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.

Pin It on Pinterest